Two weeks triple therapy with lansoprazole, amoxycillin and roxythromycin is better than dual therapy with lansoprazole and amoxycillin for h. pylori infection a randomised, clinical trial
JPMA-Journal of Pakistan Medical Association. 2000; 50 (5): 157-159
em Inglês
| IMEMR
| ID: emr-54303
ABSTRACT
AIMS:
To compare the efficacy of 2 weeks of dual therapy of Lansoprazole and Amoxycilline with triple therapy of Lansoprazole, Amoxycilline and Roxythromycin for H. pylori eradication.SUBJECTS:
Twenty-five suffering from dyspepsia and found H. pylori positive [CLO] during upper GI endoscopy.METHODS:
Patients were divided into 2 groups, one group received Lansoprazole [30 mg] once a day, and amoxycilline [500 mg] three times a day [group I], while the second group received Lansoparazole and amoxycillin in similar dosage with the addition of Roxythromycin [150 mg] twice a day [group II]. H. pylori status was confirmed on endoscopy using CLO test at entry to the protocol and then at 4 weeks. H. pylori eradication was 57% in group I and 86% in group II with healing of lesions in all cases. Better response with triple therapy [group II] indicates enhanced eradication of the pathogens with triple therapy while using roxythromycin [JPMA 50157, 2000]
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Omeprazol
/
Roxitromicina
/
Helicobacter pylori
/
Bombas de Próton
/
Quimioterapia Combinada
/
Amoxicilina
Tipo de estudo:
Ensaio Clínico Controlado
/
Guia de Prática Clínica
Limite:
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
J. Pak. Med. Assoc.
Ano de publicação:
2000
Similares
MEDLINE
...
LILACS
LIS